Literature DB >> 17662099

Central serous chorioretinopathy.

Maria Wang1, Inger Christine Munch, Pascal W Hasler, Christian Prünte, Michael Larsen.   

Abstract

Central serous chorioretinopathy (CSC) is a disease of the retina characterized by serous detachment of the neurosensory retina secondary to one or more focal lesions of the retinal pigment epithelium (RPE). CSC occurs most frequently in mid-life and more often in men than in women. Major symptoms are blurred vision, usually in one eye only and perceived typically by the patient as a dark spot in the centre of the visual field with associated micropsia and metamorphopsia. Normal vision often recurs spontaneously within a few months. The condition can be precipitated by psychosocial stress and hypercortisolism. Ophthalmoscopic signs of CSC range from mono- or paucifocal RPE lesions with prominent elevation of the neurosensory retina by clear fluid - typical of cases of recent onset - to shallow detachments overlying large patches of irregularly depigmented RPE. The spectrum of lesions includes RPE detachments. Granular or fibrinous material may accumulate in the subretinal cavity. Serous detachment often resolves spontaneously. From first contact, counselling about the potential relation to stress and glucocorticoid medication is warranted. After 3 months without resolution of acute CSC or in chronic CSC, treatment should be considered. Resolution of detachment can usually be achieved in acute CSC by focal photocoagulation of leaking RPE lesions or, in chronic CSC, by photodynamic therapy. The effect of therapy on long-term visual outcome is insufficiently documented. Reattachment within 4 months of onset is considered a relevant therapeutic target because prolonged detachment is associated with photoreceptor atrophy. This suggests that the value of treatment depends upon proper selection of cases that will not resolve without therapy. Chronic CSC may be difficult to differentiate from occult choroidal neovascularization secondary to CSC. Patients with chronic CSC who receive glucocorticoid treatment for systemic disease can often be managed without having to discontinue this medication.

Entities:  

Mesh:

Year:  2007        PMID: 17662099     DOI: 10.1111/j.1600-0420.2007.00889.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  179 in total

1.  Central serous chorioretinopathy after blunt trauma.

Authors:  Claudia Maria Prospero Ponce; Hasan M Mohidat; Charles A Garcia
Journal:  BMJ Case Rep       Date:  2012-05-26

2.  [Central serous chorioretinopathy (CSC)].

Authors:  H Baraki; N Feltgen; J Roider; H Hoerauf; C Klatt
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

3.  Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy.

Authors:  M J Koss; I Beger; F H Koch
Journal:  Eye (Lond)       Date:  2011-11-11       Impact factor: 3.775

4.  In vitro biomechanical modulation--retinal detachment in a box.

Authors:  Fredrik Ghosh; Karin Arnér; Linnéa Taylor
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-12       Impact factor: 3.117

Review 5.  Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review.

Authors:  Y-R Chung; E J Seo; H M Lew; K H Lee
Journal:  Eye (Lond)       Date:  2013-11-08       Impact factor: 3.775

6.  Neurosensory retinal detachment due to sunitinib treatment.

Authors:  A Wegner; R Khoramnia
Journal:  Eye (Lond)       Date:  2011-08-19       Impact factor: 3.775

7.  Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association Study.

Authors:  Rosa L Schellevis; Elon H C van Dijk; Myrte B Breukink; Lebriz Altay; Bjorn Bakker; Bobby P C Koeleman; Lambertus A Kiemeney; Dorine W Swinkels; Jan E E Keunen; Sascha Fauser; Carel B Hoyng; Anneke I den Hollander; Camiel J F Boon; Eiko K de Jong
Journal:  JAMA Ophthalmol       Date:  2018-10-01       Impact factor: 7.389

8.  Multilayered Deep Structure Tensor Delaunay Triangulation and Morphing Based Automated Diagnosis and 3D Presentation of Human Macula.

Authors:  Taimur Hassan; M Usman Akram; Mahmood Akhtar; Shoab Ahmad Khan; Ubaidullah Yasin
Journal:  J Med Syst       Date:  2018-10-04       Impact factor: 4.460

9.  [Central scotoma and blurred vision in a patient with Crohn's disease].

Authors:  A Caramoy; A Lappas; S Fauser; B Kirchhof
Journal:  Ophthalmologe       Date:  2009-09       Impact factor: 1.059

10.  Automated segmentation of the choroid from clinical SD-OCT.

Authors:  Li Zhang; Kyungmoo Lee; Meindert Niemeijer; Robert F Mullins; Milan Sonka; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.